← All trials
NCT05906732
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 12, 2023
- Primary completion
- Feb 3, 2024
- Completion date
- Feb 3, 2024
- First posted
- Jun 18, 2023
- Last posted
- Nov 7, 2023
- Enrollment
- 28
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Thryv Therapeutics, Inc.Lead sponsor
- Spaulding Clinical Research Inc.Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.